Work

Lysine-R2HGylation-C5 identified as a post-translational modification in R2HG-elevated cancers

Year: 2026
Type: article
Abstract: R-2-Hydroxyglutarate (R2HG), an oncometabolite predominantly produced by mutated isocitrate dehydrogenase 1/2 (IDH1/2) in various cancers, is known to drive cancer progression through noncovalent inhibition of α-ketoglutarate (αKG)-dependent enzymes. In this work, we propose an alternative mechanism wherein R2HG contributes to cancer development via covalent modification of biologically critical lysines, a process termed lysine-R2HGylation (KR2HG). We designed and synthesized R2HG-mimicking probes and demonstrated their effectiveness in facilitating KR2HG target profiling and site mapping. We identified KR2HG as a post-translational modification, confirmed its C5-linkage on GSTP1(K209), and demonstrated that SIRT5 functions as a deacylase for GSTP1-KR2HG in vitro. Furthermore, we found that R2HG slightly but significantly inhibits the enzymatic activity of GSTP1 through KR2HG and dramatically suppresses monocyte differentiation via this catalytically important lysine modification. Our findings provide an alternative perspective on the role of R2HG in leukemia progression and offer a practical tool for the clinical investigation of R2HG-elevated cancers. R-2-hydroxyglutarate is a cancer-linked metabolite whose mechanisms are incompletely understood. Here, the authors identify and structurally characterize lysineR2HGylation as a protein modification and develop probes that reveal GSTP1 as a functional target in leukemia cells.
Language: English
Open Access status: gold
Estimated APC paid: $6,990
OpenAlex ID: W4414827072
FWCI: 1.095
Cites: 58
Cited by: 1
Related to: 9